Literature DB >> 6823231

Long-term survival in multiple myeloma.

R A Kyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6823231     DOI： 10.1056/NEJM198302103080604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Robert Arthur Kyle, MD: a conversation with the editor.

Authors:  Robert Arthur Kyle; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

2.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

3.  The albumin and monoclonal protein ratio as prognostic marker for multiple myeloma in the era of novel agents.

Authors:  Katalin Kádár; Krisztina Wolf; Judit Tábori; István Karádi; Judit Várkonyi
Journal:  Pathol Oncol Res       Date:  2012-07       Impact factor: 3.201

4.  Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.

Authors:  Grzegorz S Nowakowski; Thomas E Witzig; David Dingli; Michal J Tracz; Morie A Gertz; Martha Q Lacy; John A Lust; Angela Dispenzieri; Philip R Greipp; Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2005-06-16       Impact factor: 22.113

5.  Short or long survival in multiple myeloma. A simple method for determining the prognosis.

Authors:  Judit Várkonyi; Edina Bajzik; Adám Fazakas; Sándor Sipka; István Karádi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

6.  Solitary plasmacytoma of the calvarium: a review of clinical and prognostic features.

Authors:  L Cervoni; M Salvati
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

7.  Three cases of synchronous solid tumor and multiple myeloma.

Authors:  Sang Hoon Ji; Joon Oh Park; Jeeyun Lee; Mi Jung Oh; Do Hyoung Lim; Byeong-Bae Park; Keun Woo Park; Se-Hoon Lee; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Won Ki Kang; Mark H Lee; Keunchil Park
Journal:  Cancer Res Treat       Date:  2004-10-31       Impact factor: 4.679

8.  Comparison of a new whole-body continuous-table-movement protocol versus a standard whole-body MR protocol for the assessment of multiple myeloma.

Authors:  S Weckbach; H J Michaely; A Stemmer; S O Schoenberg; D J Dinter
Journal:  Eur Radiol       Date:  2010-06-24       Impact factor: 5.315

9.  Efficacy of the M-2 protocol in previously untreated patients with advanced multiple myeloma.

Authors:  H Gössinger; P Bettelheim; E Neumann; W Hinterberger; K Korninger; H Niessner; I Pabinger-Fasching; K Bauer; K Lechner
Journal:  Blut       Date:  1984-11

10.  Late relapse in IgD myeloma: value of immunohistochemistry in trephine biopsy specimens.

Authors:  P Kettle; T C Morris
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.